196 related articles for article (PubMed ID: 38526624)
1. A revolutionary oral HBV treatment candidate as innovative therapeutic approach warranting clinical trials.
Matsui T
J Gastroenterol; 2024 May; 59(5):434-435. PubMed ID: 38526624
[No Abstract] [Full Text] [Related]
2. Latest developments in the treatment of hepatitis B.
Dandri M; Petersen J
Minerva Gastroenterol Dietol; 2016 Mar; 62(1):88-102. PubMed ID: 26448309
[TBL] [Abstract][Full Text] [Related]
3. Systematic review with network meta-analysis: Comparative efficacy of oral nucleos(t)ide analogues for the prevention of chemotherapy-induced hepatitis B virus reactivation.
Zhang MY; Zhu GQ; Shi KQ; Zheng JN; Cheng Z; Zou ZL; Huang HH; Chen FY; Zheng MH
Oncotarget; 2016 May; 7(21):30642-58. PubMed ID: 27121321
[TBL] [Abstract][Full Text] [Related]
4. Potential Drug Targets Against Hepatitis B Virus Based on Both Virus and Host Factors.
Zhang BY; Chai DP; Wu YH; Qiu LP; Zhang YY; Ye ZH; Yu XP
Curr Drug Targets; 2019; 20(16):1636-1651. PubMed ID: 31362671
[TBL] [Abstract][Full Text] [Related]
5. Prevention of hepatitis B virus reactivation in patients with hematological malignancies and resolved hepatitis B virus infection: a systematic review and meta-analysis.
Cheung CKM; Law MF; Chao DC; Wong SH; Ho R; Chao ACW; Lai JWY; Chan TYT; Tam MTK; Lau SLF; Tam THC
J Dig Dis; 2020 Mar; 21(3):160-169. PubMed ID: 32040243
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B Virus Reactivation During Successful Treatment of Hepatitis C Virus With Sofosbuvir and Simeprevir.
Collins JM; Raphael KL; Terry C; Cartwright EJ; Pillai A; Anania FA; Farley MM
Clin Infect Dis; 2015 Oct; 61(8):1304-6. PubMed ID: 26082511
[TBL] [Abstract][Full Text] [Related]
7. Is response to antiviral treatment influenced by hepatitis B virus genotype?
Raimondi S; Maisonneuve P; Bruno S; Mondelli MU
J Hepatol; 2010 Mar; 52(3):441-9. PubMed ID: 20137824
[TBL] [Abstract][Full Text] [Related]
8. Present and future DNA vaccines for chronic hepatitis B treatment.
Cova L
Expert Opin Biol Ther; 2017 Feb; 17(2):185-195. PubMed ID: 27892722
[TBL] [Abstract][Full Text] [Related]
9. Successful withdrawal of antiviral treatment in kidney transplant recipients with chronic hepatitis B viral infection.
Cho JH; Lim JH; Park GY; Kim JS; Kang YJ; Kwon O; Choi JY; Park SH; Kim YL; Kim HK; Huh S; Kim CD
Transpl Infect Dis; 2014 Apr; 16(2):295-303. PubMed ID: 24628837
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Chronic Hepatitis B Virus Infection Using Small Molecule Modulators of Nucleocapsid Assembly: Recent Advances and Perspectives.
Yang L; Liu F; Tong X; Hoffmann D; Zuo J; Lu M
ACS Infect Dis; 2019 May; 5(5):713-724. PubMed ID: 30896149
[TBL] [Abstract][Full Text] [Related]
11. Role of lamivudine in the treatment of chronic hepatitis B virus infection.
Hagmeyer KO; Pan YY
Ann Pharmacother; 1999 Oct; 33(10):1104-12. PubMed ID: 10534223
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B Virus Cure: Targets and Future Therapies.
Lee HW; Lee JS; Ahn SH
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33379331
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of hepatitis B virus in clinical trials of baricitinib in rheumatoid arthritis.
Harigai M; Winthrop K; Takeuchi T; Hsieh TY; Chen YM; Smolen JS; Burmester G; Walls C; Wu WS; Dickson C; Liao R; Genovese MC
RMD Open; 2020 Feb; 6(1):. PubMed ID: 32098857
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B Virus Screening and Management for Patients With Cancer Prior to Therapy: ASCO Provisional Clinical Opinion Update.
Hwang JP; Feld JJ; Hammond SP; Wang SH; Alston-Johnson DE; Cryer DR; Hershman DL; Loehrer AP; Sabichi AL; Symington BE; Terrault N; Wong ML; Somerfield MR; Artz AS
J Clin Oncol; 2020 Nov; 38(31):3698-3715. PubMed ID: 32716741
[TBL] [Abstract][Full Text] [Related]
15. [Clinical characteristics of hepatic flare and efficacy of antiviral therapy in pregnant women with chronic hepatitis B virus infection].
Ding Y; Sheng QJ; Zhang C; Wu YY; Yuan SY; Xia TT; An ZY; Dou XG
Zhonghua Gan Zang Bing Za Zhi; 2019 Feb; 27(2):106-111. PubMed ID: 30818914
[No Abstract] [Full Text] [Related]
16. Phage display creates innovative applications to combat hepatitis B virus.
Tan WS; Ho KL
World J Gastroenterol; 2014 Sep; 20(33):11650-70. PubMed ID: 25206271
[TBL] [Abstract][Full Text] [Related]
17. Management of viral hepatitis B.
Pramoolsinsup C
J Gastroenterol Hepatol; 2002 Feb; 17 Suppl():S125-45. PubMed ID: 12000599
[TBL] [Abstract][Full Text] [Related]
18. Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference
Cornberg M; Lok AS; Terrault NA; Zoulim F;
J Hepatol; 2020 Mar; 72(3):539-557. PubMed ID: 31730789
[TBL] [Abstract][Full Text] [Related]
19. Screening for hepatitis B virus infection in adolescents and adults: a systematic review to update the U.S. Preventive Services Task Force recommendation.
Chou R; Dana T; Bougatsos C; Blazina I; Khangura J; Zakher B
Ann Intern Med; 2014 Jul; 161(1):31-45. PubMed ID: 24861032
[TBL] [Abstract][Full Text] [Related]
20. [Advances in clinical research on rtA181 mutation in hepatitis B virus].
Gong XL; Liu R; Liu YX; Zhang Y
Zhonghua Gan Zang Bing Za Zhi; 2017 Jan; 25(1):69-72. PubMed ID: 28297788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
